Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)
NCT01176266
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
69
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypophosphatasia
Interventions
DRUG:
asfotase alfa
Sponsor
Alexion Pharmaceuticals, Inc.